Why Byrna (BYRN) Stock Is Falling Today
Byrna (NASDAQ: BYRN) shares fell 25.8% after the company reported Q2 2026 results that missed expectations. Revenue dropped 42.5% year over year to $16.39 million versus $22.22 million estimates. Byrna posted a GAAP loss of $0.44 per share versus a $0.11 loss consensus and a $0.10 profit a year earlier.
How this was made

The 30-second read
Why it matters
The reported Q2 miss versus Wall Street expectations is the immediate catalyst for the large intraday decline, likely resetting near-term expectations for growth and profitability.
Market read
A large earnings-driven gap down suggests traders should reassess valuation and near-term fundamentals, not just technical oversold conditions.
What to watch
The article does not provide guidance, backlog, or cash-flow details; traders may need those to judge whether the miss is temporary (timing/channel) or structural (demand/mix).
Background
Byrna is a non-lethal weapons company whose recent performance included strong growth, but this quarter shows a major revenue decline and GAAP loss reversal.
Ticker impact
Byrna shares fell 25.8% after Q2 revenue dropped 42.5% YoY to $16.39M and GAAP EPS swung to a $0.44 loss vs expectations.
Further volatility likely, with downside pressure until investors get clarity on demand, margins, and path back to growth.
The article cites a large same-day drop tied directly to reported Q2 results missing revenue and EPS consensus, plus a major YoY revenue decline and GAAP loss reversal.
Market effects
Signals heightened scrutiny for non-lethal weapons makers on revenue durability and margin/earnings quality.
No specific regional spillover described.
No global macro or international demand factors cited.
Counterpoint
The stock is already down sharply year-to-date, so some investors may view the selloff as overdone relative to longer-term product and dealer-channel momentum.
Key entities
- companyByrna
NASDAQ-listed non-lethal weapons company; reported Q2 2026 results that missed revenue and EPS expectations and triggered a steep stock drop.


